Contraception
News for Your Practice
FDA WARNING: Unapproved “morning after” contraceptive may be ineffective and unsafe
Consumers should not use emergency birth control called “Evital”
News for Your Practice
Contraception, well-woman visits, breastfeeding equipment—at no cost to your patients under new regs
Women will also receive screening services without fee, HHS mandates; Secy’s actions spurred by IOM guideline revision and Affordable Care Act...
Medical Education Library
10 (+1) practical, evidence-based recommendations for you to improve contraceptive care now
Don’t mandate a pelvic exam for every woman before you prescribe an OC. Use hormonal contraceptives for noncontraceptive indications. Nine other...
From the Editor
Big step forward and downward: An OC with 10 μg of estrogen
Lo Loestrin Fe delivers an ultra-low dose of ethinyl estradiol—a novel and noteworthy option when you’re considering an estrogen-progestin...
From the Editor
Levonorgestrel or ulipristal: Is one a better emergency contraceptive than the other?
Comparison of these two FDA-approved agents should take more into account than just efficacy measured by the crude pregnancy rate
Clinical Review
How to choose a contraceptive for a patient who has headaches
Developing an accurate diagnosis of headache subtype will help avert unnecessary restriction of hormonal methods among your patients who do not...
Clinical Review
What we’ve learned from 2 decades’ experience with the LNG-IUS
The latest data on long-term use, benefits, and risks of the levonorgestrel-releasing intrauterine system—to fine-tune and amplify its use in your...
From the Editor
In the news, now on the shelf: A novel estradiol-based OC
The first birth control pill was sold in the United States in 1960. Fifty years later, oral contraceptives continue to evolve—as Natazia...
From the Editor
Permanent contraception provides a lesson in cost-effective medicine
Moving interval sterilization into the office, using the hysteroscope, appears to benefit patients and society—a good thing in 2010
Clinical Review
UPDATE: CONTRACEPTION
Demand for long-acting reversible contraception is growing, including in adolescents and nulliparas. We need to challenge our historical...
News for Your Practice
FDA warning: Don’t use unapproved IUDs
Physicians who insert counterfeit IUDs may be putting themselves and their patients at risk, the FDA warns